1300 results about "Pulse rate" patented technology

A signal processor generates basis functions and identifies at least one basis function component of a sensor signal in order to calculate a physiological measurement. The signal processor is advantageously applied to pulse oximetry so as to directly calculate oxygen saturation and so as to calculate a robust oxygen saturation measurement. In particular, a signal component transform may be calculated within a window around a derived pulse rate estimate. A signal component transform may also utilize sinusoidal basis functions, and an optimization of a signal component transform may occur at a particular frequency or a set of frequencies. A sinusoidal waveform or waveforms at that frequency or set of frequencies is generated to select associated red and infrared components of the sensor signal, and an oxygen saturation is calculated from a magnitude ratio of these components.

A processor provides signal quality based limits to a signal strength operating region of a pulse oximeter. These limits are superimposed on the typical gain dependent signal strength limits. If a sensor signal appears physiologically generated, the pulse oximeter is allowed to operate with minimal signal strength, maximizing low perfusion performance. If a sensor signal is potentially due to a signal induced by a dislodged sensor, signal strength requirements are raised. Thus, signal quality limitations enhance probe off detection without significantly impacting low perfusion performance. One signal quality measure used is pulse rate density, which defines the percentage of time physiologically acceptable pulses are occurring. If the detected signal contains a significant percentage of unacceptable pulses, the minimum required signal strength is raised proportionately. Another signal quality measure used in conjunction with pulse rate density is energy ratio, computed as the percentage of total energy contained in the pulse rate fundamental and associated harmonics.

A system for long-term remote medical monitoring is especially suitable for the medical supervision of astronauts onboard a space station. The system includes at least one autonomous sensor unit (SU) with a sensor (1) and transmit/receive electrodes (2) connected to a microchip (3) and mounted on a carrier (4) in the form of an adhesive bandage that can easily be applied to the skin of the subject astronaut (11). The system further includes a body transceiver (10) that is worn on the body of the subject and acts as a centralized transmitting and receiving unit, and a portable data logger (12). Medical data such as the pulse rate and the like, as well as environmental data such as the ambient surrounding air temperature, are sensed by respective allocated sensor units (SU) and transmitted from the sensor units as electrical signals via the skin and other body tissues of the subject (11) to the body transceiver (10). From the body transceiver (10), the data signals are further transmitted, for example by a radio or infrared transmission, to the data logger (12), where the data can be recorded, displayed, processed, or further transmitted via a satellite (14) to a base station (13) or a ground-based facility such as a hospital (15). Polling signals are also transmitted from the body transceiver (10) to the sensor units (SU) in a wireless manner through the skin and other body tissues of the subject.

The invention provides a body-worn monitor that measures a patient's vital signs (e.g. blood pressure, SpO2, heart rate, respiratory rate, and temperature) while simultaneously characterizing their activity state (e.g. resting, walking, convulsing, falling). The body-worn monitor processes this information to minimize corruption of the vital signs by motion-related artifacts. A software framework generates alarms/alerts based on threshold values that are either preset or determined in real time. The framework additionally includes a series of ‘heuristic’ rules that take the patient's activity state and motion into account, and process the vital signs accordingly. These rules, for example, indicate that a walking patient is likely breathing and has a regular heart rate, even if their motion-corrupted vital signs suggest otherwise.

A wearable system or garment comprises at least three conductive electrodes that may, for example, be made of stretch-recovery electrically conductive yarns integrated with non-conductive stretch-recovery yarns that make up the remaining portion of the wearable system or garment. The wearable or garment further comprises means for using three electrodes to monitor at least one physiological or biophysical event or characteristic of the wearer. One electrode is specifically used to feed back an inverted noise signal to the wearer to destructively interfere with the wearer generated noise. Specifically, the wearer's heart rate, ECG and associated electrical characteristics may be monitored in high resolution under dry electrode conditions.

PCT No. PCT/JP97/02029 Sec. 371 Date Feb. 9, 1998 Sec. 102(e) Date Feb. 9, 1998 PCT Filed Jun. 12, 1997 PCT Pub. No. WO97/47239 PCT Pub. Date Dec. 18, 1997In order to obtain calorie expenditure with good accuracy, the device is provided with a basal metabolic state specifying element (142) which specifies the subject's basal metabolic state from his body temperature; a correlation storing element (151) which stores respective regression formulas showing the correlation between the pulse rate and the calorie expenditure when the subject is at rest or active; a correlation correcting element (152) which correcting the stored regression formulas using the basal metabolic state; a body motion determining element (104) which determines whether or not the subject is at rest; and a regression formula selecting element (153) which selects the regression formula which should be used in accordance with the results of this determination. The subject's pulse rate is applied in the selected regression formula, and the calorie expenditure corresponding to this pulse rate is calculated by calorie expenditure calculator (162).

A cardiac rhythm management system includes an atrial pacing preference (APP) filter for promoting atrial pacing. The APP filter includes an infinite impulse response (IIR) or other filter that controls the timing of delivery of atrial pacing pulses. The atrial pacing pulses are delivered at an APP-indicated pacing rate that is typically at a small amount above the intrinsic atrial heart rate. For sensed beats, the APP indicated rate is increased until it becomes slightly faster than the intrinsic atrial heart rate. The APP-indicated pacing rate is then gradually decreased to search for the underlying intrinsic atrial heart rate. Then, after a sensed atrial beat, the APP filter again increases the pacing rate until it becomes faster than the intrinsic atrial rate by a small amount. As a result, most atrial heart beats are paced, rather than sensed. This decreases the likelihood of the occurrence of an atrial tachyarrhythima, such as atrial fibrillation. The decreased likelihood of atrial tachyarrhythmia, in turn, decreases the likelihood of inducing a ventricular arrhythmia, either as a result of the atrial tachyarrhythmia, or as the result of delivering a defibrillation shock to treat the atrial tachyarrhythmia.

Program products, methods, and systems for providing fitness monitoring services are disclosed. In an embodiment, a method for providing heart rate information to a user of a portable fitness monitoring service includes: (a) defining a plurality of heart rate zones as ranges of percentages of a maximum heart rate; (b) associating a color with each of said heart rate zones; (c) receiving heart rate information from the user; and (d) providing a graphical display of the heart rate information, wherein a color of a portion of the graphical display corresponds with the color associated with one of said heart rate zones, wherein steps (a)-(d) are executed using at least one processor.

A monitoring device (20) and method (200) for monitoring the health of a user is disclosed herein. The monitoring device (20) is preferably a watch (25), an optical sensor (30) disposed on a band of the watch (25), a circuitry assembly (35) embedded within a main body of the watch (25), a display member (40) disposed on an exterior surface of the main of the watch, and a control component (43). The monitoring device (20) preferably displays the following information about the user: pulse rate; blood oxygenation levels; calories expended by the user of a pre-set time period; target zones of activity; time; distance traveled; and dynamic blood pressure. The watch (25) also displays the time of day on the display member (40).

A cardiac monitor is provided that monitors the condition of the heart of a cardiac patient and generates signals indicating one of several conditions, such as supraventricular tachycardia, ventricular tachycardia and ventricular fibrillation. In order to generate these signals, the ECG from the patient is analyzed to determine a cardiac interval and heart rate, as well as a waveform factor and a waveform factor irregularity. The waveform factor is derived from the average of the ECG amplitudes during a cardiac interval and the peak value of the ECG during the same interval. Preferably, a running average is calculated over several intervals. This waveform factor is then used to detect shockable ventricular arrhythmia. The waveform factor irregularity is indicative of the variability of the waveform factor and is used to differentiate between ventricular tachycardia and ventricular defibrillation.

Pacing systems are disclosed including detectors for detecting the presence of electromagnetic interference and setting an interference state pacing mode and pacing rate. The interference state pacing mode and pacing rate are altered as a function of patient pacemaker dependency and the prevailing mean heart rate. When pacemaker dependency exists, the pacing rate is maintained and even increased from the prevailing mean heart for the duration of the interference state. When the patient is determined to not be pacemaker dependent, pacing is inhibited or suspended for the duration of the interference state.

A method of diagnosing pulmonary congestion is provided. At least one decrease in a trans-thoracic impedance value from a baseline trans-thoracic impedance value is sensed. At least one increase in a heart rate value from a baseline heart rate value is also sensed. Pulmonary congestion is diagnosed if the decrease in the trans-thoracic impedance value corresponding to the increase in the heart rate does not increase after a predetermined interval. Systems and programs incorporating the method are also provided.

A monitoring device (20) and method (200) for monitoring the health of a user is disclosed herein. The monitoring device (20) preferably includes eyewear (25) with an optical sensor (30), a digital storage and processing device (35) with a display member (40) and a control component (43), and a connection cable (45). The monitoring device (20) preferably displays the following information about the user: pulse rate; calories expended by the user of a pre-set time period; target zones of activity; time; and distance traveled.

A method and device for measuring a patient's pulse rate and blood pressure and also the condition of the blood vessel access can be accurately monitored by identifying a frequency component of the pressure wave caused by the patient's heartbeat among other pressure waves in a fluid by frequency analysis. The method and device are used when a medical device is connected to the patient's blood vessel via a blood vessel access and has a mechanical device for applying pressure to a fluid to transport it to said blood vessel.

A maternal-fetal monitoring system for use during all stages of pregnancy, including antepartum and intrapartum stages. The maternal-fetal monitoring system of the subject invention comprises (1) a set of sensors; (2) an amplifying/filtering means; (3) a computing means; and (4) a graphical user interface. Accurate clinical data, which can be extracted and provided to the user in real-time using the system of the invention, include without limitation, maternal electrocardiogram (ECG) signals, maternal uterine activity signals (EHG), maternal heart rate, fetal ECG signals, and fetal heart rate. In a preferred embodiment, the maternal-fetal monitoring system of the invention includes an intelligence means, such as a neural network system, to analyze and interpret clinical data for use in clinical diagnosis antepartum, intrapartum and postpartum, as well as delivery strategy.